David Hirsch - Net Worth and Insider Trading
David Hirsch Net Worth
The estimated net worth of David Hirsch is at least $11 Million dollars as of 2024-11-13. David Hirsch is the Director of Poseida Therapeutics Inc and owns about 2,714,245 shares of Poseida Therapeutics Inc (PSTX) stock worth over $10 Million. David Hirsch is the Director of Collegium Pharmaceutical Inc and owns about 17,117 shares of Collegium Pharmaceutical Inc (COLL) stock worth over $537,645. David Hirsch is also the Director, 10% Owner of Molecular Templates Inc and owns about 279,902 shares of Molecular Templates Inc (MTEM) stock worth over $92,760. Besides these, David Hirsch also holds Tricida Inc (TCDAQ) . Details can be seen in David Hirsch's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Hirsch has not made any transactions after 2020-07-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Hirsch
David Hirsch Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Hirsch owns 5 companies in total, including Poseida Therapeutics Inc (PSTX) , Tricida Inc (TCDAQ) , and Molecular Templates Inc (MTEM) among others .
Click here to see the complete history of David Hirsch’s form 4 insider trades.
Insider Ownership Summary of David Hirsch
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PSTX | Poseida Therapeutics Inc | 2020-07-14 | director |
| TCDAQ | Tricida Inc | 2018-07-02 | director & 10 percent owner |
| MTEM | Molecular Templates Inc | 2019-11-25 | director & 10 percent owner |
 | | 2019-11-08 | director & 10 percent owner |
| | 2021-07-14 | director & 10 percent owner |
David Hirsch Latest Holdings Summary
David Hirsch currently owns a total of 4 stocks. Among these stocks, David Hirsch owns 2,714,245 shares of Poseida Therapeutics Inc (PSTX) as of July 14, 2020, with a value of $10 Million and a weighting of 94.08%. David Hirsch owns 17,117 shares of Collegium Pharmaceutical Inc (COLL) as of November 8, 2019, with a value of $537,645 and a weighting of 5.05%. David Hirsch also owns 279,902 shares of Molecular Templates Inc (MTEM) as of November 25, 2019, with a value of $92,760 and a weighting of 0.87%. The other 1 stocks Tricida Inc (TCDAQ) have a combined weighting of 0% among all his current holdings.
Latest Holdings of David Hirsch
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PSTX | Poseida Therapeutics Inc | 2020-07-14 | 2,714,245 | 3.69 | 10,015,564 |
| COLL | Collegium Pharmaceutical Inc | 2019-11-08 | 17,117 | 31.41 | 537,645 |
| MTEM | Molecular Templates Inc | 2019-11-25 | 279,902 | 0.33 | 92,760 |
| TCDAQ | Tricida Inc | 2018-07-02 | 3,023,366 | 0.00 | 30 |
Holding Weightings of David Hirsch
David Hirsch Form 4 Trading Tracker
According to the SEC Form 4 filings, David Hirsch has made a total of 1 transactions in Poseida Therapeutics Inc (PSTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Poseida Therapeutics Inc is the acquisition of 250,000 shares on July 14, 2020, which cost David Hirsch around $4 Million.
According to the SEC Form 4 filings, David Hirsch has made a total of 0 transactions in Collegium Pharmaceutical Inc (COLL) over the past 5 years. The most-recent trade in Collegium Pharmaceutical Inc is the sale of 25,000 shares on November 8, 2019, which brought David Hirsch around $483,250.
According to the SEC Form 4 filings, David Hirsch has made a total of 2 transactions in Molecular Templates Inc (MTEM) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Molecular Templates Inc is the acquisition of 62,467 shares on November 25, 2019, which cost David Hirsch around $7 Million.
More details on David Hirsch's insider transactions can be found in the Insider Trading History of David Hirsch table.Insider Trading History of David Hirsch
- 1
David Hirsch Trading Performance
GuruFocus tracks the stock performance after each of David Hirsch's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David Hirsch is 15.47%. GuruFocus also compares David Hirsch's trading performance to market benchmark return within the same time period. The performance of stocks bought by David Hirsch within 3 months outperforms 3 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David Hirsch's insider trading performs compared to the benchmark.
Performance of David Hirsch
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.08 | | | | | |
| Relative Return to S&P 500(%) | 9.56 | | | | | |
David Hirsch Ownership Network
Ownership Network List of David Hirsch
Ownership Network Relation of David Hirsch
David Hirsch Owned Company Details
What does Poseida Therapeutics Inc do?
Who are the key executives at Poseida Therapeutics Inc?
David Hirsch is the director of Poseida Therapeutics Inc. Other key executives at Poseida Therapeutics Inc include President & Cell Therapy Kristin Yarema , 10 percent owner Malin Life Sciences Holdings Ltd , and director & 10 percent owner & Chief Executive Officer Eric Ostertag .
Poseida Therapeutics Inc (PSTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Poseida Therapeutics Inc (PSTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Poseida Therapeutics Inc (PSTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Poseida Therapeutics Inc (PSTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Poseida Therapeutics Inc Insider Transactions
David Hirsch Mailing Address
Above is the net worth, insider trading, and ownership report for David Hirsch. You might contact David Hirsch via mailing address: C/o Longitude Capital Partners, Llc, 800 El Camino Real, Suite 220, Menlo Park Ca 94025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
